Center & Institute Affiliations
Contact Info
Research Interests
drug utilization; drug safety; drug effectiveness; pharmacoepidemiology; risk adjustment; comorbidity scores
Additional Links
Experiences & Accomplishments
Dr. Mehta is a pharmacist with expertise in pharmaceutical health outcomes research. Dr. Mehta's research interests are in pharmacoepidemiology, real world evidence, comparative effectiveness research and risk adjustment. Dr. Mehta uses large administrative claims, electronic medical records and national survey data to determine drug utilization patterns and safety and effectiveness of pharmaceutical interventions.
Honors & Awards
Honors
2010 Inductee, Rho Chi Honor Society University of Houston
Awards
2010 & 2011 Poster Finalist Award, 15th and 16th ISPOR annual meeting
2011 & 2012 Travel Grant and SAS Junior Professional Award, South Central SAS User’s Group (SCSUG)
2012 Travel Grant, 48th DIA annual meeting, Philadelphia, PA
2012 Travel Grant, 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), Barcelona, Spain
2014 Graduate Student Excellence Award, College of Pharmacy, University of Houston
2015 Certificate of Outstanding Contribution in Reviewing, Value in Health
2019 Top 10% reviewer, Annals of Internal Medicine
Select Publications
Selected publications:
Mehta HB, An H, Andersen KM, et al. Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study. Ann Intern Med. 2021;174(10):1395-1403. doi:10.7326/M21-0857
Mehta HB, Mehta V, Girman CJ, Adhikari D, Johnson ML. Regression coefficient-based scoring system should be used to assign weights to the risk index. J Clin Epidemiol. 2016;79:22-28.
Mehta HB, Kuo YF, Raji MA, et al. State Variation in Chronic Opioid Use in Long-Term Care Nursing Home Residents. J Am Med Dir Assoc. 2021;22(12):2593-2599.e4. doi:10.1016/j.jamda.2021.04.016
Ardeshirrouhanifard S, An H, Goyal RK, Raji MA, Alexander GC, Mehta HB. Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016. Pharmacotherapy. 2022;10.1002/phar.2679. doi:10.1002/phar.2679
Mehta HB, Yong S, Sura SD, Hughes BD, Kuo YF, Williams SB, Tyler DS, Riall TS, Goodwin JS. Development of comorbidity score for patients undergoing major surgery. Health Serv Res. 2019.